Oncoethix

OncoEthix is a privately held biotechnology company aiming to develop a small portfolio of oncology drug candidates

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

OncoEthix is a privately held biotechnology company aiming to develop a small portfolio of oncology drug candidates. The Company’s lead product, OTX015, is an investigational orally administered synthetic small molecule targeted to BET bromodomain proteins 2/3/4.

02Backed By1 investor

MMedicxi→

03Similar Companies